Niaid preclinical development support - production of cgmp native flexibly linked HIV-1 envelope protein
Active Awarded Last action
- Contract number
- HHSN27200031
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,545,732
Award facts
- Contract value 100% obligated
- $9,545,732.00 Current and potential, with all options
- Completion date 88% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $185,516 | |
| Change Order | $335,921 | |
| Funding Only Action | $403,922 | |
| Change Order | $2,509,960 | |
| Original award | $6,110,413 |
About this award
This is a $9,545,732.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for the production of cGMP native flexibly linked HIV-1 envelope protein to support NIAID's preclinical development efforts. This contract is not set aside and is part of a larger $24 million Diagnostics Pre-Clinical Services Program indefinite delivery vehicle (IDV) that ABL holds with NIAID. ABL has also been awarded several other IDVs with NIAID and other NIH institutes, demonstrating its extensive capabilities in biopharmaceutical research and development, particularly in the areas of vaccine and therapeutic development for infectious diseases and cancer.
Quick answers
Who was awarded contract HHSN27200031?
HHSN27200031 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 12, 2016.
How much is contract HHSN27200031 worth?
The government has obligated $9,545,732 on HHSN27200031.
Is contract HHSN27200031 an order under another contract?
Yes. HHSN27200031 is a delivery order under HHSN272201100021I, an indefinite delivery contract.
Was contract HHSN27200031 competed?
The extent of competition for HHSN27200031 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award